Skip to main content

Year: 2023

Agricultural Biologicals Market to Reach USD 29.31 Billion by 2029 | Exclusive Report by Fortune Business Insights™

Key segments covered in agricultural biologicals market are By Type (Biopesticides, Biostimulants, Biofertilizers), By Source (Microbial, Biochemicals), By Application Method (Foliar Spray, Soil Treatment, Seed Treatment, Others), By Crop (Row Crops, Fruits & Vegetables, Others), and Regional Forecast, 2022–2029.Agricultural Biologicals MarketAgricultural Biologicals MarketPune, India, Nov. 20, 2023 (GLOBE NEWSWIRE) — The global agricultural biologicals market size was valued at USD 10.25 billion in 2021 and is projected to grow from USD 11.66 billion in 2022 to USD 29.31 billion by 2029, exhibiting a CAGR of 14.07% during the forecast period. This information is provided by Fortune Business Insights, in its report titled, “Agricultural Biologicals Market, 2022-2029.” Agricultural biologicals, also known as biopesticides...

Continue reading

Wagyu Beef Market Size to Reach USD 34.87 Billion by 2029 | Exclusive Report by Fortune Business Insights™

Key companies covered in Wagyu beef market are Blackmore Wagyu (Australia), Agri Beef Co. (U.S.), Australian Agricultural Company Limited (Australia), Starzen Co., Ltd (Japan), Stockyard Pty Ltd (Australia), Lone Mountain Wagyu, LLC (U.S.), Jack’s Creek (Australia), Sugar Mountain (U.S.), Stanbroke (Australia), Beefcorp Australia Pty Ltd (Australia) and more players profiled.Wagyu Beef MarketWagyu Beef Market SizePune, India, Nov. 20, 2023 (GLOBE NEWSWIRE) — The global wagyu beef market size was USD 21.42 billion in 2021 and is projected to grow from USD 22.64 billion in 2022 to USD 34.87 billion by 2029, exhibiting a CAGR of 6.37% during the forecast period 2022-2029. The Wagyu beef market has experienced substantial growth and global recognition in recent years, driven by the increasing demand for premium and...

Continue reading

Sea Buckthorn Market Size, Share, Regional Trends, Demand and Forecast 2030 | Exclusive Report by Fortune Business Insights™

Key companies covered in sea buckthorn market are SeabuckWonders, Wellash, W.S. Badger Company, Inc., Natures Aid Ltd, Erbology, SIBU, Weleda, Leh Berry, Natura Health Product, Terezia and other players. Pune, India, Nov. 20, 2023 (GLOBE NEWSWIRE) — The global sea buckthorn market size is estimated to grow at a proliferating rate owing to the increasing application of the plant in the pharmaceutical and cosmetics industry, states Fortune Business Insights™ in its report “Sea Buckthorn Market Size, Share and Industry Analysis, and Regional Forecast, 2023-2030”. Sea buckthorn’s leaves and fruits are a good source of vitamins K, E, C, & A, flavonoids, carotenoids, and organic acids and are utilized on a large scale in the industry due to their nutritional benefits.  According to developing research in China, the consumption...

Continue reading

Standard Lithium Provides Comprehensive Results of Its Fully Optimized and Proven DLE Process

Ready to Scale: Setting the Pace in the Smackover With a Tested, Optimized and Proven DLE Process and a Highly Skilled Operations Team EL DORADO, Ark., Nov. 20, 2023 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI) (FRA:S5L), a leading near-commercial lithium development company, today shared detailed performance results from its Direct Lithium Extraction (DLE) process at its Demonstration Plant (Plant) near El Dorado, Arkansas. Standard Lithium’s Demonstration Plant is the only truly large-scale, continuously operating DLE plant in North America. Initially commissioned in May 2020, the Plant has operated on a 24/7 basis since then (aside from turnaround due to equipment upgrades in the plant and brine supply interruptions). To date, the Plant has processed over...

Continue reading

Shampoo Bar Market Projected to Reach USD 15.07 Billion by 2030 | Fortune Business Insights™

Companies leading the Shampoo Bar Market are LUSH (U.K.), L’Oréal S.A. (France), The Procter & Gamble Company (U.S.), Grüum Europe Ltd. (U.K.), HiBAR (U.S.), Carol’s Daughter (U.S.), Ethique, Inc. (New Zealand), Davines International (Italy), Shiseido Co. Ltd. (Japan), L’Occitane Groupe S.A. (France), and more.Shampoo Bar MarketShampoo Bar MarketPune, India, Nov. 20, 2023 (GLOBE NEWSWIRE) — The global shampoo bar market size was valued at USD 10.07 billion in 2022 and is projected to grow from USD 10.53 billion in 2023 to USD 15.07 billion by 2030, exhibiting a CAGR of 5.3% during the forecast period of 2023-2030. Solid shampoo bars are used as hair cleansing products produced using herbal oils, conditioners, butter, and gentle cleansers. Rising awareness among the young population regarding the benefits...

Continue reading

Novartis showcases significant data updates from Kisqali®, iptacopan and Scemblix® at SABCS and ASH

Late-breaking final iDFS analysis from NATALEE investigating Kisqali® (ribociclib) in broad population of patients with stage II and III HR+/HER2- early breast cancer, including those with node-negative diseaseNew 48-week efficacy and safety data from the Phase III APPLY-PNH trial of investigational oral monotherapy iptacopan in anti-C5-treated adult patients with paroxysmal nocturnal hemoglobinuria (PNH) and persistent anemiaNearly 4 year follow-up efficacy and safety results from end of study treatment update of ASCEMBL with Scemblix® (asciminib) in patients with Ph+ chronic phase-chronic myeloid leukemia (CP-CML) after ≥2 Prior Tyrosine Kinase InhibitorsBasel, November 20, 2023 — Novartis will present data from over 100 trials across its breast cancer and hematology portfolios at the 2023 San Antonio Breast Cancer Symposium...

Continue reading

Continued strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers third sales milestone payment for the region from Pfizer this year

Allschwil, Switzerland, November 20, 2023 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the continued strong sales performance of the antifungal Cresemba® (isavuconazole) by its license partner Pfizer Inc. (NYSE: PFE, “Pfizer”) in the Asia Pacific region and China exceeded the sales threshold triggering a further USD 1.25 million milestone payment. David Veitch, Basilea’s Chief Executive Officer, stated: “This marks the third sales milestone payment for Asia Pacific and China this year. It highlights that Cresemba continues to serve a high medical need and also reflects the significant commercial potential of Cresemba in this region. We are pleased to see that Cresemba is well on...

Continue reading

Marine Collagen Market Size to Hit USD 1,919.30 Million by 2030 | 159 Pages Research Report

Key companies in the marine collagen market are Ashland Inc. (U.S.), Certified Nutraceuticals Inc. (U.S.), COBIOSA (Spain), ETChem (China), Hangzhou Nutrition Biotechnology Co., Ltd. (China), HUM Nutrition Inc. (U.S.), Nitta Gelatin Inc. (U.S.), Norland Products Inc. (U.S.), Rousselot (U.S.), Vital Proteins LLC (U.S.), and more.Marine Collagen MarketMarine Collagen Market SizePune, India, Nov. 20, 2023 (GLOBE NEWSWIRE) — The global marine collagen market size was valued at USD 1,007.40 million in 2022 and is expected to be worth USD 1,080.40 million in 2023. The market is projected to reach USD 1,919.30 million by 2030, recording a CAGR of 8.56% during the forecast period. Marine collagen is a type of collagen extracted from fish and other marine organisms and is consumed by individuals to enhance their health and immunity....

Continue reading

Teck Receives Regulatory Approval for Share Buy-Back Program

VANCOUVER, British Columbia, Nov. 20, 2023 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) has been informed that the Toronto Stock Exchange (“TSX”) has accepted the notice filed by Teck to establish a normal course issuer bid to purchase its Class B subordinate voting shares (“Class B Shares”). Under the normal course issuer bid, Teck may purchase up to 40 million Class B Shares during the period starting November 22, 2023, and ending November 21, 2024, representing approximately 7.8% of the outstanding Class B Shares, or 7.9% of the public float, as at November 15, 2023. 512,316,533 Class B Shares were issued and outstanding as at that date. Teck will make any purchases through the facilities of the TSX, the New York Stock Exchange or other alternative trading systems in Canada and the...

Continue reading

Nokia AVA Energy Efficiency in SaaS model selected by Globe Telecom Philippines to cut network power use

Press release  Nokia AVA Energy Efficiency in SaaS model selected by Globe Telecom Philippines to cut network power useNokia AVA for Energy Efficiency SaaS uses artificial intelligence and machine learning to reduce energy consumption across the network while maintaining network performance Deal expands existing strategic partnership between the two companies 20 November 2023 Espoo, Finland – Nokia today announced that its AVA Energy Efficiency software, to be delivered in a SaaS delivery model, has been selected by Globe Telecom to help the Philippine communication service provider drive lower network power consumption and costs.  Nokia AVA for Energy SaaS, using artificial intelligence and machine learning algorithms, will enable Globe to shut idle and unused equipment automatically during low usage periods. The solution delivers...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.